Clinical Trial Update: Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating efficacy, mechanisms, and safety of SGLT2 inhibitors in kidney transplant recipients, including post-transplant diabetes mellitus, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Recipients
• Post-transplant Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University Health Network, Toronto | Conditions: Kidney Transplant Recipients, Post-transplant Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2026-06-08